Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is a systemic disease associated with the proliferation and accumulation (usually in granulomas) of Langerhans cells in various tissues.

Hypercalcemia

An abnormally increased calcium concentration in the blood.


合計: 5

                      


(表示件数)
PMID (PMCID)
12571475
FEMALE Infant
Hypercalcemia in Langerhans cell histiocytosis: is it therapy-related?
Jubinsky PT.
J Pediatr Hematol Oncol. 2003;25(2):176-9.
Hypercalcemia is not known to be a common occurrence in patients with Langerhans cell histiocytosis (LCH).
11792606
FEMALE Middle Aged
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level.
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H.
Bone. 2002;30(1):331-4.
Whereas hypercalcemia has been described in several granulomatous disorders and is secondary to unregulated extrarenal production of 1,25 dihydroxyvitamin D, it is, however, extremely rare in Langerhans' cell granulomatosis.
11792606
FEMALE Middle Aged
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level.
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H.
Bone. 2002;30(1):331-4.
This is the first case report of Langerhans' cell granulomatosis with hypercalcemia and documented elevated increased 1,25 dihydroxyvitamin D level that responded to the treatment of her primary disease.
11792606
FEMALE Middle Aged
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level.
Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H.
Bone. 2002;30(1):331-4.
Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level.
8689352
MALE Infant
Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin.
McLean TW, Pritchard J.
J Pediatr Hematol Oncol. 1996;18(3):318-20.
Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin.